Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 20,500 shares, a decline of 32.1% from the May 15th total of 30,200 shares. Based on an average daily volume of 210,100 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are sold short.

Terumo Stock Performance

TRUMY stock traded down $0.14 during midday trading on Friday, reaching $17.83. 170,886 shares of the company's stock traded hands, compared to its average volume of 164,411. The company has a current ratio of 3.00, a quick ratio of 1.78 and a debt-to-equity ratio of 0.12. Terumo has a 52-week low of $14.06 and a 52-week high of $21.22. The stock has a market cap of $26.40 billion, a P/E ratio of 34.29 and a beta of 0.80. The stock's 50-day moving average is $18.73 and its 200 day moving average is $18.81.

Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.07). Terumo had a net margin of 11.28% and a return on equity of 8.48%. The business had revenue of $1.79 billion for the quarter, compared to the consensus estimate of $1.79 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.